CareDx Statistics
Total Valuation
CareDx has a market cap or net worth of $1.11 billion. The enterprise value is $937.10 million.
Important Dates
The last earnings date was Tuesday, April 28, 2026, after market close.
| Earnings Date | Apr 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CareDx has 51.66 million shares outstanding. The number of shares has decreased by -9.13% in one year.
| Current Share Class | 51.66M |
| Shares Outstanding | 51.66M |
| Shares Change (YoY) | -9.13% |
| Shares Change (QoQ) | +3.92% |
| Owned by Insiders (%) | 4.24% |
| Owned by Institutions (%) | 100.60% |
| Float | 49.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 26.93 |
| PS Ratio | 2.69 |
| Forward PS | 2.45 |
| PB Ratio | 3.52 |
| P/TBV Ratio | 4.61 |
| P/FCF Ratio | 17.13 |
| P/OCF Ratio | 15.23 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 404.62, with an EV/FCF ratio of 14.45.
| EV / Earnings | n/a |
| EV / Sales | 2.27 |
| EV / EBITDA | 404.62 |
| EV / EBIT | n/a |
| EV / FCF | 14.45 |
Financial Position
The company has a current ratio of 3.40, with a Debt / Equity ratio of 0.08.
| Current Ratio | 3.40 |
| Quick Ratio | 2.93 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 2.54 |
| Debt / FCF | 0.38 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -2.36% and return on invested capital (ROIC) is -8.58%.
| Return on Equity (ROE) | -2.36% |
| Return on Assets (ROA) | -1.80% |
| Return on Invested Capital (ROIC) | -8.58% |
| Return on Capital Employed (ROCE) | -3.92% |
| Weighted Average Cost of Capital (WACC) | 17.56% |
| Revenue Per Employee | $539,634 |
| Profits Per Employee | -$10,708 |
| Employee Count | 765 |
| Asset Turnover | 0.92 |
| Inventory Turnover | 5.21 |
Taxes
In the past 12 months, CareDx has paid $181,000 in taxes.
| Income Tax | 181,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +27.37% in the last 52 weeks. The beta is 2.49, so CareDx's price volatility has been higher than the market average.
| Beta (5Y) | 2.49 |
| 52-Week Price Change | +27.37% |
| 50-Day Moving Average | 18.58 |
| 200-Day Moving Average | 16.77 |
| Relative Strength Index (RSI) | 60.36 |
| Average Volume (20 Days) | 852,471 |
Short Selling Information
The latest short interest is 6.40 million, so 12.38% of the outstanding shares have been sold short.
| Short Interest | 6.40M |
| Short Previous Month | 6.42M |
| Short % of Shares Out | 12.38% |
| Short % of Float | 12.93% |
| Short Ratio (days to cover) | 10.45 |
Income Statement
In the last 12 months, CareDx had revenue of $412.82 million and -$8.19 million in losses. Loss per share was -$0.16.
| Revenue | 412.82M |
| Gross Profit | 284.37M |
| Operating Income | -13.00M |
| Pretax Income | -8.01M |
| Net Income | -8.19M |
| EBITDA | 2.32M |
| EBIT | -13.00M |
| Loss Per Share | -$0.16 |
Full Income StatementBalance Sheet
The company has $187.18 million in cash and $24.50 million in debt, with a net cash position of $173.58 million or $3.36 per share.
| Cash & Cash Equivalents | 187.18M |
| Total Debt | 24.50M |
| Net Cash | 173.58M |
| Net Cash Per Share | $3.36 |
| Equity (Book Value) | 313.54M |
| Book Value Per Share | 6.11 |
| Working Capital | 190.24M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $72.95 million and capital expenditures -$8.10 million, giving a free cash flow of $64.85 million.
| Operating Cash Flow | 72.95M |
| Capital Expenditures | -8.10M |
| Depreciation & Amortization | 15.32M |
| Net Borrowing | n/a |
| Free Cash Flow | 64.85M |
| FCF Per Share | $1.26 |
Full Cash Flow StatementMargins
Gross margin is 68.88%, with operating and profit margins of -3.15% and -1.98%.
| Gross Margin | 68.88% |
| Operating Margin | -3.15% |
| Pretax Margin | -1.94% |
| Profit Margin | -1.98% |
| EBITDA Margin | 0.56% |
| EBIT Margin | -3.15% |
| FCF Margin | 15.71% |
Dividends & Yields
CareDx does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 9.13% |
| Shareholder Yield | 9.13% |
| Earnings Yield | -0.74% |
| FCF Yield | 5.84% |
Analyst Forecast
The average price target for CareDx is $28.00, which is 30.23% higher than the current price. The consensus rating is "Buy".
| Price Target | $28.00 |
| Price Target Difference | 30.23% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CareDx has an Altman Z-Score of 4.5 and a Piotroski F-Score of 4.
| Altman Z-Score | 4.5 |
| Piotroski F-Score | 4 |
